Dr Mohd Faheem Mubeen

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Comparative study to evaluate efficacy and safety of pioglitazone versus voglibose on glycemic parameters in prediabetes patients add on metformin
  INTERNATIONAL JOURNAL OF CURRENT MEDICAL AND PHARMACEUTICAL RESEARCH 2019
  +Save
• DRUG UTILIZATION PATTERN OF ANTI-DIABETIC DRUGS AMONG DIABETIC OUTPATIENTS IN A TERTIARY CARE HOSPITAL
  http://www.ijprjournal.org/showpdf/MjAya2FsYWkxNDc4NTIzNjk= 2019
  +Save
• Evaluation of Efficacy and Tolerability of Fixed Dose Combination of Metformin with Voglibose Versus Metformin with Pioglitazone in Prediabetics: An Open label, prospective, RCT
  Journal of Drug Delivery and Therapeutics 2019
  +Save
• Effectiveness Treatment for Diabetes Prevention: 6-Months Results from the Prediabetes
  International Journal of Innovative Research in Medical Science 2019 DOI: 10.23958/ijirms/vol04-i06/692
  +Save
• Evaluation of Effect of Vitamin D Supplementation on Glycemic Control in Patients of Type 2 Diabetes Mellitus
  Journal of Diabetes & Metabolism 2018 DOI: 10.4172/2155-6156.1000806
  +Save
• Comparative Evaluation of Safety and Efficacy of Pioglitazone versus Voglibose on Lipid Level in Prediabetes Patient Add on Metformin
  Scholars Journal of Applied Medical Sciences 2018
  +Save
• Comparative Evaluation of Pioglitazone versus Voglibose on Lipid Profile in Patients with Type 2 Diabetes Mellitus Add On Metformin
  Scholars Journal of Applied Medical Sciences 2018
  +Save
• Ecopharmacovigilance
  Journal of Medical Science And clinical Research 2018 DOI: 10.18535/jmscr/v6i3.140
  +Save
• Comparative evaluation of Pioglitazone versus Voglibose on glycemic control in patients with Type 2 Diabetes Mellitus on Metformin
  Journal of Medical Science And clinical Research 2018 DOI: 10.18535/jmscr/v6i7.135
  +Save
• Comparative study to evaluate efficacy and safety of azilsartan and telmisartan in patients with grade I-II essential hypertension
  International Journal of Basic & Clinical Pharmacology 2017 DOI: 10.18203/2319-2003.ijbcp20175697
  +Save